Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers L > Headlines for Leiner Health Products Inc. > News item |
Leiner Health Products to start roadshow Wednesday for $150 million eight-year notes
By Paul A. Harris
St. Louis, May 11 - Leiner Health Products Inc. will start a roadshow Wednesday for a $150 million offering of eight-year senior subordinated notes (expected ratings B3/CCC+), a syndicate source said.
Pricing is expected on May 20 or May 21.
UBS Investment Bank, Credit Suisse First Boston and Morgan Stanley are joint bookrunners for the Rule 144A offering.
The notes will come with four years of call protection.
Proceeds will be used to acquire capital stock as part of NorthCastle and Golden Gate Capital's recapitalization of the company.
The company is a Carson, Calif.-based manufacturer of supplements, diet aids and over-the-counter pharmaceuticals.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.